Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quintiles Transnational Holdings Inc Acquires Novella Clinical


Wednesday, 14 Aug 2013 09:30am EDT 

Quintiles Transnational Holdings Inc announced that it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on oncology customers as well as those in the medical device and diagnostics sectors.